Literature DB >> 30814872

hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA regulatory circuits in breast cancer.

Yasemin Öztemur Islakoğlu1, Senem Noyan1, Bala Gür Dedeoğlu1.   

Abstract

Breast cancer is the most common cancer among women and the molecular pathways that play main roles in breast cancer regulation are still not completely understood. MicroRNAs (miRNAs) and transcription factors (TFs) are important regulators of gene expression. It is important to unravel the relation of TFs, miRNAs, and their targets within regulatory networks to clarify the processes that cause breast cancer and the progression of it. In this study, mRNA and miRNA expression studies including breast tumors and normal samples were extracted from the GEO microarray database. Two independent mRNA studies and a miRNA study were selected and reanalyzed. Differentially expressed (DE) mRNAs and miRNAs between breast tumor and normal samples were listed by using BRBArray Tools. CircuitsDB2 analysis conducted with DE miRNAs and mRNAs resulted in 3 significant circuits that are SOX10- and hsamiR-301a-dependent. The following significant circuits were characterized and validated bioinformatically by using web-based tools: SOX10→hsa-miR-301aHOXA3, SOX10→hsa-miR-301a→KIT, and SOX10→hsa-miR-301aNFIB. It can be concluded that regulatory motifs involving miRNAs and TFs may be useful for understanding breast cancer regulation and for predicting new biomarkers.

Entities:  

Keywords:  Breast cancer; mRNA; miRNA; regulatory circuits; transcription factor

Year:  2018        PMID: 30814872      PMCID: PMC6353269          DOI: 10.3906/biy-1708-17

Source DB:  PubMed          Journal:  Turk J Biol        ISSN: 1300-0152


  2 in total

1.  miR-519 regulates the proliferation of breast cancer cells via targeting human antigen R.

Authors:  Lili Ren; Yong Li; Qun Zhao; Liqiao Fan; Bibo Tan; Aimin Zang; Hua Yang
Journal:  Oncol Lett       Date:  2019-12-20       Impact factor: 2.967

2.  Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.

Authors:  Xiaodong Xu; Yingjie Xia; Jie Ma; Weijun Li; Nan Niu; Xiao Li; Houquan Tao; Ji Xu; Xujun He
Journal:  Int J Oncol       Date:  2020-05-26       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.